IFG
TEVA icon

Independent Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Independent Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,998
Closed -$82.7K – 782
2022
Q2 		$82.7K Sell
10,998
-1,134
-9% -$9.88K 0.01% 683
2022
Q1 		$114K Buy
12,132
+1,524
+14% +$12.7K 0.01% 755
2021
Q4 		$85K Buy
10,608
+210
+2% +$1.9K 0.01% 760
2021
Q3 		$101K Buy
+10,398
New +$97.4K 0.01% 698
2021
Q1 		– Sell
-10,426
Closed -$101K – 673
2020
Q4 		$101K Sell
10,426
-2,696
-21% -$25.8K 0.01% 549
2020
Q3 		$118K Buy
+13,122
New +$139K 0.02% 486

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Independent Financial Group's TEVA Position: Q3 2022 in Review

Independent Financial Group sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 10,998 shares — an estimated $82.7K sold.

Independent Financial Group first reported a position in TEVA in Q3 2020 and held it in 6 quarters. The position peaked at $118K in Q3 2020. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Independent Financial Group reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Independent Financial Group sold 10,998 Teva Pharmaceuticals shares in Q3 2022, an estimated $82.7K.
  • Independent Financial Group first reported a position in Teva Pharmaceuticals in Q3 2020 and held it in 6 quarters.
  • Independent Financial Group's Teva Pharmaceuticals position peaked at $118K in Q3 2020.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Independent Financial Group's 13F filing for Q3 2022, filed 15 Jun 2026.